Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute stroke after intravitreal bevacizumab to treat choroidal neovascularization due to angioid streaks in pseudoxanthoma elasticum : a severe systemic adverse event after an off-label procedure.

Literature DB >> 23065017

Acute stroke after intravitreal bevacizumab to treat choroidal neovascularization due to angioid streaks in pseudoxanthoma elasticum : a severe systemic adverse event after an off-label procedure.

Gianluca Besozzi¹, Andrea Ferrara, Enrico Epifani, Daniela Intini, Margherita Apruzzese, Antonio Provenzano, Michele Vetrugno.

Abstract

To report the occurrence of acute stroke after intravitreal bevacizumab administration to treat choroidal neovascularization due to angioid streaks in a patient affected by pseudoxanthoma elasticum. A 54-year-old man with pseudoxanthoma elasticum had vision loss because of choroidal neovascularization due to angioid streaks. He underwent two intravitreal bevacizumab injections. Three days after the second procedure the patient was afflicted by acute stroke. Intravitreal injection of bevacizumab to treat choroidal neovascularization due to angioid streaks in pseudoxanthoma elasticum could lead to severe systemic adverse events.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2012 PMID： 23065017 DOI： 10.1007/s10792-012-9647-9

Source DB: PubMed Journal: Int Ophthalmol ISSN： 0165-5701 Impact factor: 2.031

19 in total

1. Angioid streaks. I. Ophthalmoscopic variations and diagnostic problems.

Authors: J A Shields; J L Federman; T L Tomer; W H Annesley
Journal: Br J Ophthalmol Date: 1975-05 Impact factor: 4.638

2. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.

Authors: Michele Rinaldi; Roberto Dell'Omo; Mario R Romano; Flavia Chiosi; Ugo Cipollone; Ciro Costagliola
Journal: Arch Ophthalmol Date: 2007-10

3. Macular translocation for subfoveal choroidal neovascularization in angioid streaks.

Authors: D B Roth; M Estafanous; H Lewis
Journal: Am J Ophthalmol Date: 2001-03 Impact factor: 5.258

4. Prevalence of symptomatic intracranial aneurysm and ischaemic stroke in pseudoxanthoma elasticum.

Authors: J S van den Berg; R C Hennekam; J R Cruysberg; P M Steijlen; J Swart; N Tijmes; M Limburg
Journal: Cerebrovasc Dis Date: 2000 Jul-Aug Impact factor: 2.762

5. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.

Authors: Andrew C Browning; A K K Chung; F Ghanchi; S P Harding; M Musadiq; S J Talks; Y C Yang; W M Amoaku
Journal: Ophthalmology Date: 2005-07 Impact factor: 12.079

Review 6. Angioid streaks.

Authors: J G Clarkson; R D Altman
Journal: Surv Ophthalmol Date: 1982 Mar-Apr Impact factor: 6.048

Review 7. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.

Authors: N Chassaing; L Martin; P Calvas; M Le Bert; A Hovnanian
Journal: J Med Genet Date: 2005-05-13 Impact factor: 6.318

8. Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

Authors: Daniel F Martin; Maureen G Maguire; Gui-shuang Ying; Juan E Grunwald; Stuart L Fine; Glenn J Jaffe
Journal: N Engl J Med Date: 2011-04-28 Impact factor: 91.245

9. Long-term control of choroidal neovascularisation secondary to angioid streaks treated with intravitreal bevacizumab (Avastin).

Authors: P Neri; S Salvolini; C Mariotti; L Mercanti; S Celani; A Giovannini
Journal: Br J Ophthalmol Date: 2008-10-29 Impact factor: 4.638

10. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

Authors: Usha Chakravarthy; Simon P Harding; Chris A Rogers; Susan M Downes; Andrew J Lotery; Sarah Wordsworth; Barnaby C Reeves
Journal: Ophthalmology Date: 2012-05-11 Impact factor: 12.079

3 in total